News for MediciNova, Inc. (MNOV)

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

MediciNova Inc. (MNOV), a biopharmaceutical company, experienced a notable stock movement with a 5.50% increase, trading at $2.11 per share. The trading volume

NIH-funded Phase 2-3 ALS Expanded Access study expands reach of MediciNova's ongoing COMBAT-ALS trial and provides illustration of Company's development strate

**media[466851]**

**media[462662]**

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

Academic group to receive a total of $22 million for the trial...

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...

Shares of Recursion Pharmaceuticals, Inc. RXRX dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptom...

Israel-based thermal energy business Brenmiller Energy Ltd (BNRG) is up over 122 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.

Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.

/PRNewswire/ -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added...

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Read Analysts’ New Coverage for May 24th (AAMC, AAU, ACU, ADXS, ALDX, APLD, AUMN, AZN, CFTLF, CRBP) at ETF Daily News

During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive ...